Vanguard Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $157M | Buy |
|
|||||
|
2025
Q1 | $576M | Sell |
|
|||||
|
2024
Q4 | $1.1B | Buy |
|
|||||
|
2024
Q3 | $1.12B | Sell |
|
|||||
|
2024
Q2 | $1.43B | Buy |
|
|||||
|
2024
Q1 | $1.14B | Sell |
|
|||||
|
2023
Q4 | $850M | Buy |
|
|||||
|
2023
Q3 | $1.04B | Buy |
|
|||||
|
2023
Q2 | $977M | Buy |
|
|||||
|
2023
Q1 | $1.12B | Buy |
|
|||||
|
2022
Q4 | $1.04B | Sell |
|
|||||
|
2022
Q3 | $894M | Sell |
|
|||||
|
2022
Q2 | $631M | Buy |
|
|||||
|
2022
Q1 | $650M | Buy |
|
|||||
|
2021
Q4 | $748M | Buy |
|
|||||
|
2021
Q3 | $692M | Buy |
|
|||||
|
2021
Q2 | $580M | Buy |
|
|||||
|
2021
Q1 | $549M | Buy |
|
|||||
|
2020
Q4 | $1.23B | Buy |
|
|||||
|
2020
Q3 | $996M | Sell |
|
|||||
|
2020
Q2 | $1.14B | Buy |
|
|||||
|
2020
Q1 | $640M | Buy |
|
|||||
|
2019
Q4 | $824M | Buy |
|
|||||
|
2019
Q3 | $479M | Buy |
|
|||||
|
2019
Q2 | $947M | Buy |
|
|||||
|
2019
Q1 | $715M | Buy |
|
|||||
|
2018
Q4 | $640M | Buy |
|
|||||
|
2018
Q3 | $870M | Buy |
|
|||||
|
2018
Q2 | $689M | Buy |
|
|||||
|
2018
Q1 | $382M | Buy |
|
|||||
|
2017
Q4 | $283M | Buy |
|
|||||
|
2017
Q3 | $224M | Buy |
|
|||||
|
2017
Q2 | $144M | Buy |
|
|||||
|
2017
Q1 | $121M | Buy |
|
|||||
|
2016
Q4 | $108M | Buy |
|
|||||
|
2016
Q3 | $226M | Buy |
|
|||||
|
2016
Q2 | $59.2M | Buy |
|
|||||
|
2016
Q1 | $57.5M | Buy |
|
|||||
|
2015
Q4 | $110M | Buy |
|
|||||
|
2015
Q3 | $82.6M | Buy |
|
|||||
|
2015
Q2 | $76.1M | Buy |
|
|||||
|
2015
Q1 | $32.2M | Buy |
|
|||||
|
2014
Q4 | $33.1M | Buy |
|
|||||
|
2014
Q3 | $46.6M | Sell |
|
|||||
|
2014
Q2 | $66.4M | Buy |
|
|||||
|
2014
Q1 | $50.6M | Buy |
|
|||||
|
2013
Q4 | $42M | Buy |
|
|||||
|
2013
Q3 | $81.9M | Buy |
|
|||||
|
2013
Q2 | $61.1M | Buy |
|